Indaptus Therapeutics Files 8-K Under 'Other Events'

Ticker: INDP · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1857044

Indaptus Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyIndaptus Therapeutics, INC. (INDP)
Form Type8-K
Filed DateJul 16, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-k, corporate-event

TL;DR

Indaptus Therapeutics filed an 8-K for an 'Other Event' on 7/14. Details TBD.

AI Summary

Indaptus Therapeutics, Inc. filed an 8-K on July 16, 2025, reporting an event on July 14, 2025. The filing is categorized under 'Other Events' and does not specify any material agreements, asset acquisitions, or executive changes. The company, formerly known as Intec Parent Inc., is incorporated in Delaware and headquartered in New York.

Why It Matters

This 8-K filing indicates a corporate event has occurred for Indaptus Therapeutics, Inc., though the specific nature of the event is not detailed in the provided excerpt, requiring further investigation.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' without immediate disclosure of significant financial or operational changes.

Key Players & Entities

FAQ

What specific event is being reported under 'Other Events' in this 8-K filing?

The provided excerpt does not specify the nature of the 'Other Events' reported by Indaptus Therapeutics, Inc. Further details within the full filing would be required to answer this question.

When was Indaptus Therapeutics, Inc. formerly known as Intec Parent Inc.?

The company's name change from Intec Parent Inc. to Indaptus Therapeutics, Inc. occurred on April 14, 2021.

What is the principal executive office address for Indaptus Therapeutics, Inc.?

The principal executive offices are located at 3 Columbus Circle, 15th Floor, New York, New York 10019.

What is the SIC code for Indaptus Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Indaptus Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

What is the Commission File Number for Indaptus Therapeutics, Inc.?

The Commission File Number for Indaptus Therapeutics, Inc. is 001-40652.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Indaptus Therapeutics, Inc. (INDP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing